Ghemaxan

Ghemaxan is an anticoagulant medication containing Enoxaparin Sodium, used to prevent and treat blood clots. It is suitable for haemodialysis, intravenous, and subcutaneous use.

Ghemaxan is primarily used to prevent and treat blood clots in various medical conditions. It is often prescribed for patients undergoing haemodialysis or those at risk of deep vein thrombosis. Enoxaparin Sodium, the active ingredient, helps to thin the blood and reduce the risk of clotting. This medication is commonly used in hospital settings and for long-term management of clotting disorders.

Ghemaxan may cause common side effects such as bruising, bleeding, and pain at the injection site. Some users may experience more serious effects like allergic reactions or unusual bleeding. It is important to monitor for any signs of adverse reactions and consult a healthcare provider if concerns arise.

Ghemaxan should be handled with care to avoid contamination and ensure proper dosage. It is important to follow the prescribed administration route, whether haemodialysis, intravenous, or subcutaneous. Patients should inform their healthcare provider about any allergies or medical conditions before using this medication.

Ghemaxan may interact with other medications, particularly those that affect blood clotting. Alcohol and certain foods may also influence its effectiveness. It is advisable to consult a healthcare provider about potential interactions before starting this medication.